These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12653496)

  • 1. Further development of reduced graphs for identifying bioactive compounds.
    Barker EJ; Gardiner EJ; Gillet VJ; Kitts P; Morris J
    J Chem Inf Comput Sci; 2003; 43(2):346-56. PubMed ID: 12653496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scaffold hopping using clique detection applied to reduced graphs.
    Barker EJ; Buttar D; Cosgrove DA; Gardiner EJ; Kitts P; Willett P; Gillet VJ
    J Chem Inf Model; 2006; 46(2):503-11. PubMed ID: 16562978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similarity searching using reduced graphs.
    Gillet VJ; Willett P; Bradshaw J
    J Chem Inf Comput Sci; 2003; 43(2):338-45. PubMed ID: 12653495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Training similarity measures for specific activities: application to reduced graphs.
    Birchall K; Gillet VJ; Harper G; Pickett SD
    J Chem Inf Model; 2006; 46(2):577-86. PubMed ID: 16562986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A knowledge-based weighting approach to ligand-based virtual screening.
    Stiefl N; Zaliani A
    J Chem Inf Model; 2006; 46(2):587-96. PubMed ID: 16562987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target family-directed exploration of scaffolds with different SAR profiles.
    Hu Y; Bajorath J
    J Chem Inf Model; 2011 Dec; 51(12):3138-48. PubMed ID: 22091691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling promiscuity based on in vitro safety pharmacology profiling data.
    Azzaoui K; Hamon J; Faller B; Whitebread S; Jacoby E; Bender A; Jenkins JL; Urban L
    ChemMedChem; 2007 Jun; 2(6):874-80. PubMed ID: 17492703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Bayes affinity fingerprints" improve retrieval rates in virtual screening and define orthogonal bioactivity space: when are multitarget drugs a feasible concept?
    Bender A; Jenkins JL; Glick M; Deng Z; Nettles JH; Davies JW
    J Chem Inf Model; 2006; 46(6):2445-56. PubMed ID: 17125186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The reduced graph descriptor in virtual screening and data-driven clustering of high-throughput screening data.
    Harper G; Bravi GS; Pickett SD; Hussain J; Green DV
    J Chem Inf Comput Sci; 2004; 44(6):2145-56. PubMed ID: 15554685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High confidence predictions of drug-drug interactions: predicting affinities for cytochrome P450 2C9 with multiple computational methods.
    Hudelson MG; Ketkar NS; Holder LB; Carlson TJ; Peng CC; Waldher BJ; Jones JP
    J Med Chem; 2008 Feb; 51(3):648-54. PubMed ID: 18211009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From activity cliffs to activity ridges: informative data structures for SAR analysis.
    Vogt M; Huang Y; Bajorath J
    J Chem Inf Model; 2011 Aug; 51(8):1848-56. PubMed ID: 21761918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of topological indices: computer-oriented approach.
    Skvortsova MI; Palyulin VA; Zefirov NS
    SAR QSAR Environ Res; 2009; 20(3-4):357-77. PubMed ID: 19544196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of belief theory to similarity data fusion for use in analog searching and lead hopping.
    Muchmore SW; Debe DA; Metz JT; Brown SP; Martin YC; Hajduk PJ
    J Chem Inf Model; 2008 May; 48(5):941-8. PubMed ID: 18416545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular fingerprints: flexible molecular descriptors with applications from physical chemistry to ADME.
    Glem RC; Bender A; Arnby CH; Carlsson L; Boyer S; Smith J
    IDrugs; 2006 Mar; 9(3):199-204. PubMed ID: 16523386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationship anatomy by network-like similarity graphs and local structure-activity relationship indices.
    Wawer M; Peltason L; Weskamp N; Teckentrup A; Bajorath J
    J Med Chem; 2008 Oct; 51(19):6075-84. PubMed ID: 18798611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction of a generally applicable method to estimate retrieval of active molecules for similarity searching using fingerprints.
    Vogt M; Bajorath J
    ChemMedChem; 2007 Sep; 2(9):1311-20. PubMed ID: 17562536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hidden component of size in two-dimensional fragment descriptors: side effects on sampling in bioactive libraries.
    Dixon SL; Koehler RT
    J Med Chem; 1999 Jul; 42(15):2887-900. PubMed ID: 10425098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs and nondrugs: an effective discrimination with topological methods and artificial neural networks.
    Murcia-Soler M; Pérez-Giménez F; García-March FJ; Salabert-Salvador MT; Díaz-Villanueva W; Castro-Bleda MJ
    J Chem Inf Comput Sci; 2003; 43(5):1688-702. PubMed ID: 14502504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARANEA: a freely available program to mine structure-activity and structure-selectivity relationship information in compound data sets.
    Lounkine E; Wawer M; Wassermann AM; Bajorath J
    J Chem Inf Model; 2010 Jan; 50(1):68-78. PubMed ID: 20053000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ErG: 2D pharmacophore descriptions for scaffold hopping.
    Stiefl N; Watson IA; Baumann K; Zaliani A
    J Chem Inf Model; 2006; 46(1):208-20. PubMed ID: 16426057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.